Clever Fruit Products (“Clever Fruit”) is pleased to announce they will attend SupplySide West 2019 in Las Vegas next week. This will be Clever Fruit’s second year in attendance, and this year’s event will gather over 17,000 ingredient buyers and suppliers from various sectors in the health and nutrition industry.
Sean Sears, Chairman of Clever Fruit, will lead the team alongside its President, Liam Tayler. With the results from their first animal trial, Clever Fruit is intending to bring their scientific findings along with their product prototype to the show to meet with industry experts. “In the past year, Clever Fruit has achieved many of its milestones,” said Sears, “we have finished our first animal trial and now have our first product prototype ready for a second round. We believe attending this year’s SupplySide West will be a beneficial move forward in further modeling our product to meet both our objectives and the market’s needs.”
About SupplySide West 2019:
The 23rd 2019 SupplySide West unites more than 17,000 ingredient buyers and sellers from dietary supplements, food, beverage, personal care, sports nutrition, and processing innovation. SupplySide West is all about the science and strategy around the development of finished products that drive the global business economy. This year Supply Side West gather 1,300 exhibitors and provides 140 hours of educational and conference programming.
About Clever Fruit Products:
Clever Fruit Products (“Clever Fruit”) is a functional food ingredients manufacturer targeting improved health outcomes. Clever Fruit’s technology is a unique approach to fermentation that draws out the full nutrient profile of the underlying fruit while creating new compounds. While Clever Fruit’s proprietary process can work with any fruit, its focus is on wild blueberry, apple, and cranberry. Its initial product is based on the wild blueberry and early trials suggest a potential to reduce cholesterol by 40% and reduce LDL oxidation, lowering the possibility of plaque formation in the arteries.
For more information, please contact: